Scientist Sees Risk in High Celebrex Doses (Reuters)


Reuters - Pfizer Inc.'s pain drug
Celebrex has a "probable increased risk" of heart attacks in
higher doses but "no apparent effect" in 200 milligram doses or
less, a veteran U.S. Food and Drug Administration scientist
said on Thursday in a written presentation.

Read more...